background
human
immunodefici
viru
type
infecti
viral
agent
gradual
extinguish
immun
system
result
acquir
immun
defici
syndrom
aid
aim
studi
construct
rnaposit
control
base
armor
ar
rna
technolog
use
rna
model
method
maturas
coat
protein
gene
posit
pol
gene
clone
plasmid
prepar
plasmid
transform
escherichia
coli
strain
express
construct
induc
mm
isopropyllthiodgalactopyranosid
iptg
h
obtain
fabric
ar
rna
ar
rna
precipit
purifi
use
polyethylen
glycol
sephacryl
chromatographi
result
stabil
ar
rna
evalu
treatment
dnase
rnase
confirm
transmiss
electron
microscopi
gel
agaros
electrophoresi
tenfold
serial
dilut
ar
rna
prepar
realtim
pcr
assay
rang
detect
addit
r
valu
slope
standard
curv
conclus
prepar
ar
rna
posit
control
could
use
basi
launch
inhous
viru
assay
infecti
agent
readili
avail
laboratori
hiv
research
center
ar
rna
noninfecti
highli
resist
ribonucleas
enzym
reduc
risk
infect
clinic
laboratori
uman
immunodefici
viru
hiv
infect
one
critic
challeng
global
public
health
accur
evalu
hiv
type
rna
level
import
factor
understand
natur
histori
hiv
infect
monitor
progress
diseas
acquir
immun
defici
syndrom
aid
determin
efficaci
antiretrovir
therapi
pcrbase
assay
common
method
evalu
virus
relat
transcript
biolog
sampl
howev
control
revers
transcript
step
pcr
reaction
especi
appli
control
similar
templat
sequenc
critic
requir
method
research
recent
report
encapsid
target
rna
anoth
viral
capsid
improv
rna
stabil
singlestrand
rna
ssrna
viru
positiveh
sens
strand
icosahedr
capsid
belong
levivirida
famili
genom
size
nearli
kb
encod
four
protein
includ
coat
protein
maturas
protein
aprotein
lysi
protein
replicas
protein
attach
fertil
factor
f
e
coli
enter
bacteria
use
maturas
protein
enter
bacteria
viral
rna
act
messeng
rna
translat
structur
protein
assembl
stage
one
molecul
viral
ssrna
one
copi
maturas
protein
aprotein
copi
coat
kda
protein
requir
phage
packag
start
bind
copi
coat
protein
specif
region
hairpinlik
structur
consist
nucleotid
locat
near
side
phage
genom
among
nucleotid
residu
act
recognit
site
hairpin
play
role
phage
packag
structur
capsid
maturas
protein
protect
phage
particl
degrad
ribonucleas
enzym
accord
armor
ar
rna
technolog
almost
exogen
rna
appropri
size
integr
downstream
pac
site
phage
genom
nonspecif
assembl
express
phage
capsid
lead
format
target
ar
rna
phagelik
particl
plp
quantifi
ar
rna
use
substitut
control
standard
clinic
diagnosi
viru
rna
rtpcr
qrtpcr
aim
studi
provid
insight
product
ribonucleaseresist
ar
rna
plp
use
rna
model
base
ar
rna
technolog
e
coli
strain
use
host
strain
express
target
hiv
pol
plasmid
contain
ampicillin
resist
gene
promot
use
express
vector
studi
commerci
phage
purchas
sigmaaldrich
germani
maturas
coat
protein
gene
bp
pol
bp
gene
amplifi
specif
primer
tabl
amplifi
sequenc
clean
clone
bamhihindiii
site
plasmid
use
standard
protocol
result
plasmid
propag
e
coli
extract
qiagen
miniprep
plasmid
extract
kit
qiagen
germani
per
manufactur
instruct
gener
recombin
plasmid
hiv
pcr
product
first
digest
hindiii
fermentas
usa
noti
takara
japan
restrict
enzym
digest
product
clean
qiagen
pcr
cleanup
kit
clone
hindiii
noti
site
downstream
pac
site
dna
fragment
describ
tabl
primer
sequenc
use
pcr
realtim
pcr
amplif
verifi
direct
dna
sequenc
digest
restrict
enzym
prior
insert
linear
e
coli
strain
harbor
cultur
l
lb
broth
medium
contain
ampicillin
grown
shake
incub
h
protein
express
induc
ad
mm
isopropyllthiodgalactopyranosid
iptg
condit
h
subsequ
bacteri
pellet
collect
centrifug
disrupt
sonic
cell
debri
remov
centrifug
min
supernat
contain
ar
rna
particl
e
coli
genom
dna
plasmid
rna
dna
contamin
remov
treatment
mm
cacl
rnase
dnase
thermo
fisher
scientif
usa
supernat
collect
transfer
conic
tube
follow
slow
addit
nacl
final
concentr
constant
gentl
stir
next
polyethylen
glycol
peg
ad
final
concentr
mixtur
stir
h
ensur
complet
solubil
peg
beaker
transfer
refriger
viru
protein
allow
precipit
h
precipit
collect
centrifug
minut
precipit
suspend
small
volum
te
buffer
trishci
ph
edta
nacl
final
ar
purifi
sephacryl
resin
te
buffer
mm
tri
ph
mm
edta
mm
nacl
plp
stabil
analyz
agaros
gel
electrophoresi
stain
gel
red
dye
intact
ar
confirm
transmiss
electron
microscopi
tem
follow
neg
stain
phosphotungst
acid
number
plp
determin
uv
spectrophotometri
use
avogadro
constant
extinct
coeffici
mgml
bacteriophag
per
absorb
unit
od
nm
molecular
weight
previous
describ
primer
probe
design
alelleid
ver
beacon
design
ver
premier
biosoft
usa
confirm
conserv
region
pol
gene
genom
latter
sequenc
download
hiv
databas
http
wwwhivlanlgovcontentindex
truncat
insert
downstream
genom
primer
probe
sequenc
shown
tabl
sent
metabion
compani
germani
synthesi
report
dye
fluorescein
amidit
fam
carboxyfluorescein
black
hole
quencher
dy
conjug
end
tenfold
serial
dilut
contain
ar
particl
assay
rna
molecul
first
releas
incub
min
realtim
pcr
detect
perform
use
step
one
realtim
pcr
instrument
appli
biosystem
usa
well
quantitect
probe
rtpcr
kit
qiagen
germani
taqman
master
mix
reaction
prepar
perform
buffer
nm
forward
revers
primer
nm
probe
ar
rna
rt
reaction
last
min
follow
denatur
step
min
cycl
without
fluoresc
collect
follow
cycl
anneal
extens
fluoresc
signal
acquir
annealingextens
step
figur
illustr
maturas
coat
protein
gene
pol
gene
bp
obtain
rtpcr
rna
roch
germani
use
iii
onestep
rtpcr
system
taq
highfidel
dna
polymeras
kit
invitrogen
usa
ar
particl
precipit
peg
neg
stain
phosphotungst
acid
tem
imag
confirm
ar
particl
icosahedr
shape
diamet
fig
complet
resist
dnase
rnase
treatment
h
fig
wherein
nake
rna
degrad
rapidli
previous
describ
particl
detect
band
migrat
bp
moreov
stabil
nake
ar
rna
evalu
incub
mm
tri
ph
mm
nacl
mm
mgcl
tsm
six
month
ar
rna
stabl
although
nake
rna
rapidli
degrad
fig
sdspage
analysi
induc
confirm
express
protein
fig
express
protein
close
report
size
kda
capsid
protein
phage
indic
success
express
design
e
coli
tenfold
serial
dilut
prepar
rtpcr
first
perform
standard
obtain
limit
detect
lod
assay
shown
figur
assay
lod
vari
r
valu
standard
curv
slope
respect
suggest
constantli
high
amplif
effici
greater
polymeras
chain
assay
commonli
use
quantit
qualit
diagnosi
evalu
viral
load
hivinfect
patient
number
method
vitro
transcript
produc
posit
rna
intern
extern
control
pcr
assay
rna
molecul
unstabl
hard
condit
high
ph
high
temperatur
addit
rna
easili
degrad
presenc
dival
cation
moreov
rnase
abund
environ
even
minor
contamin
make
rna
molecul
extrem
vulner
therefor
synthesi
rna
improv
stabil
import
nucleicacidbas
assay
past
decad
ar
rna
technolog
develop
improv
stabil
rna
use
standard
control
clinic
diagnost
assay
base
use
ar
rna
technolog
target
rna
synthes
e
coli
transform
plasmid
assembl
along
phage
genom
capsid
plp
contain
target
sequenc
resist
ribonucleas
enzym
aim
current
studi
construct
positivecontrol
rna
base
ar
rna
technolog
use
rna
model
construct
positivecontrol
ar
rna
bp
genom
contain
maturas
coat
packag
sequenc
clone
plasmid
moreov
bp
pol
conserv
region
genom
ligat
downstream
gen
recombin
plasmid
transfer
e
coli
strain
ar
rna
assembl
follow
iptg
induct
also
shown
durabl
ar
rna
presenc
ribonucleas
enzym
sequenc
coat
gene
overlap
region
lysi
gene
phage
mplifi
pcr
prepar
plasmid
could
produc
larg
number
plp
without
bacteri
lysi
therefor
produc
plp
infecti
accord
biosafeti
concern
comparison
stabil
armor
ar
rna
nake
rna
concentr
nake
ar
rna
estim
measur
od
absorb
nm
thermo
ar
rna
stabl
nake
rna
rapidli
degrad
previou
studi
subtyp
b
rna
packag
ar
rna
howev
domin
subtyp
iranian
patient
b
c
present
studi
rna
sequenc
bp
encapsul
plp
use
express
vector
e
coli
strain
pm
current
plp
purif
method
involv
combin
use
gradient
ultracentrifug
column
chromatographi
co
affin
chromatographi
rnaprotein
complex
electroelut
agaros
gel
gebaflextub
present
studi
plp
precipit
peg
purifi
sephacryl
ar
rna
stabl
treatment
dnase
rnase
result
similar
previou
studi
anoth
studi
part
viru
genom
pack
phage
capsid
plp
assembl
base
ar
rna
technolog
moreov
studi
burchard
et
al
cyber
green
dye
use
perform
pcr
reaction
present
studi
use
taqman
method
specif
dsdnabind
dye
furthermor
studi
phage
use
intern
control
monitor
cdna
synthesi
step
clinic
specimen
nucleic
acid
prepar
process
includ
lysi
pathogen
addit
ar
rna
challeng
ribounucleas
enzym
stabil
ar
rna
compar
nake
rna
result
current
studi
indic
stabil
ar
rna
presenc
ribonucleas
enzym
durabl
ar
rna
nake
rna
similar
previou
studi
current
studi
plp
standard
prepar
use
posit
control
realtim
rtpcr
duplic
realtim
rtpcr
assay
high
sensit
lod
channel
fam
ar
rna
indic
constantli
high
amplif
effici
sever
commerci
rna
control
variou
infecti
agent
base
ar
technolog
due
high
cost
control
usag
limit
develop
countri
result
obtain
studi
could
basi
stabil
infecti
agent
moreov
develop
virusbas
control
requir
accur
analysi
evalu
panel
infecti
agent
well
posit
sampl
posit
control
use
basi
launch
inhous
viru
assay
made
readili
avail
laboratori
hiv
research
center
